Korean health-tech start-up, Ybrain, is developing wearable technology that they believe can slow down the effects of Alzheimer’s and other degenerative brain disorders.

During an interview with Forbes, CEO and Founder of Ybrain, Kiwon Lee, said: “Our ambition is to challenge one of the toughest problems humanity faces today. Cancer is nearing a cure, but we don’t yet have a cure for Alzheimer’s, even with today’s most advanced medical technology.”

Ybrain’s device comprises of a headband with two sensors embedded in the front that transmits electronic signals to stimulate brain activity. Lee says the headband is a “very non-invasive form of brain stimulation” more favourable than taking pills.

Ybrain is also building a mobile health platform that will collect the brain signal data from the devices so it can be used for more targeted and personalised treatment.

Since it was founded in 2013, the company has secured $4.2 million worth of funding from several Korean VCs and carried out clinical trials with the Samsung Medical Center in Seoul.

Ybrain plans to tackle a series of degenerative neurological disorders, but also plans to help people who want to improve their normal neurological functioning by conditioning the brain to work at higher levels.

“Our patented headsets can be worn at home and monitored from a lab, and will help alleviate a series of neurological disorders, including addiction, trauma, dieting and schizophrenia,” said Lee. The startup is currently running clinical trials using the same technology to treat clinical depression and mild cognitive impairment (MCI).

Ybrain plans to release two devices, Brain Wellness and Brain Fullness, to treat disorders and enhance brain function, respectively.

Although the company has received approval from the Food and Drug Association (FDA) to start clinical trials, it’s currently pursuing Korea Food and Drug Association (KFDA) approval and plans to release their devices to the market by 2016.

For more information contact news@eHealthNews.co.za, like us on Facebook or tweet us @eHealthNewsZA.